Results 331 to 340 of about 1,075,882 (382)
Some of the next articles are maybe not open access.

INTRAPERITONEAL CHEMOTHERAPY

Obstetrics and Gynecology Clinics of North America, 1994
Despite high initial tumor response rates to systemically administered platinum-based chemotherapy, fewer than one quarter of advanced-stage ovarian cancer patients currently experience prolonged disease-free survival. Because persistent and relapsed disease tends to remain confined to the peritoneal cavity, the strategy of enhancing drug delivery to ...
Michael F. Flessner, Robert L. Dedrick
  +6 more sources

Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.

JAMA Oncology, 2021
Importance The peritoneal surface is a common site of disease in ovarian and colorectal cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic efforts, including surgical removal of tumor deposits and intravenous chemotherapy ...
R. V. van Stein   +3 more
semanticscholar   +1 more source

Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial

Journal of Surgical Oncology, 2021
The PERISCOPE I (Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyPErthermic intraperitoneal chemotherapy) study was conducted to investigate the safety and feasibility of hyperthermic intraperitoneal ...
W. Koemans   +12 more
semanticscholar   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review

Diseases of the Colon & Rectum, 2021
BACKGROUND: Combined treatment modality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is emerging as an alternative option for colorectal peritoneal metastases, but there is ambiguity regarding patient selection, treatment ...
Manasi Parikh   +6 more
semanticscholar   +1 more source

Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis

Diseases of the Colon & Rectum, 2021
Supplemental Digital Content is available in the text. BACKGROUND: Synchronous liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases have traditionally been contraindicated ...
M. Flood   +8 more
semanticscholar   +1 more source

Intraperitoneal Chemotherapy with Melphalan

Annals of Internal Medicine, 1984
We administered melphalan by the intraperitoneal route to investigate its toxicity and pharmacokinetics. The drug was instilled with 2 litres of fluid and allowed to dwell in the peritoneal cavity for 4 hours. No local toxicity was detected by clinical examination, laboratory tests, or histologic examination.
S B, Howell, C E, Pfeifle, R A, Olshen
openaire   +2 more sources

Pharmacology of Intraperitoneal Chemotherapy

Cancer Investigation, 1983
In this review of the pharmacology and clinical application of intraperitoneal drug administration, we have tried to acquaint the reader with the current state of the art. At this juncture it is important to outline briefly some of the major remaining questions.
C E, Myers, J M, Collins
openaire   +2 more sources

Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer

The journal of obstetrics and gynaecology research, 2020
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a method of administering anticancer agents directly while heating the abdominal cavity. The aim of this review is to know the current position of HIPEC in ovarian cancer and uterine sarcoma and its ...
H. Tsuyoshi   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy